C3.ai stock fell amid a massive rout in artificial intelligence stocks earlier in the week. Is C3.ai stock a sell now? Shares ...

C3.ai Inc. closed 30.46% below its 52-week high of $45.08, which the company achieved on December 10th.

Investors should be on high alert for more AI-stock weakness after DeepSeek disrupted markets and sent shares tumbling.

Wall Street shocked by DeepSeek AI's low-cost, high-performance model using reduced-capacity Nvidia GPUs. Competitors take a hit, but potential for innovation and affordability in AI technology.

KBC Group NV grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 3,862.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange ...

Royal Bank of Canada reiterated their sector perform rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a report released on Wednesday,Benzinga reports. Royal Bank of Canada ...

U.S. President Donald Trump on Friday acknowledged that tariff costs are sometimes passed along to consumers, and said his plans to impose tariffs may cause a short-term disruption.